This provider's $95.6M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 254% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 59% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $2.8K | $2.1K | 1.32x | $681.31 | $4.4M | 2.1K | 5 |
| 2015 | $1.9K | $1.4K | 1.35x | $498.05 | $4.1M | 2.9K | 8 |
| 2016 | $1.3K | $860.17 | 1.52x | $443.58 | $5.2M | 6.0K | 10 |
| 2017 | $1.2K | $805.83 | 1.48x | $383.44 | $5.7M | 7.1K | 10 |
| 2018 | $1.6K | $1.0K | 1.55x | $553.84 | $8.6M | 8.6K | 11 |
| 2019 | $2.6K | $1.6K | 1.67x | $1.0K | $9.9M | 6.4K | 7 |
| 2020 | $2.8K | $1.9K | 1.53x | $979.46 | $10.9M | 5.9K | 7 |
| 2021 | $3.1K | $2.4K | 1.28x | $667.28 | $17.3M | 7.2K | 7 |
| 2022 | $3.1K | $1.8K | 1.68x | $1.2K | $14.0M | 7.6K | 7 |
| 2023 | $3.2K | $2.1K | 1.53x | $1.1K | $15.5M | 7.5K | 6 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81479 | Molecular pathology procedure | 18.5K | $53.4M | $2.9K | 1.39x |
| 0018U | Microrna gene analysis of thyroid nodule tissue | 6.7K | $19.1M | $2.9K | 1.50x |
| 84999 | Chemistry procedures | 2.9K | $8.8M | $3.0K | 1.32x |
| 0245U | Gene analysis of 10 genes and 37 rna fusions and expression of 4 mrna markers, next-generation sequencing, in fine needle aspirate of thyroid to evaluate risk of thyroid cancer | 4.9K | $7.5M | $1.6K | 2.03x |
| 81445 | Test for detecting genes associated with cancer of body organ | 3.6K | $2.1M | $588.98 | 3.31x |
| 81455 | Test for detecting genes associated with cancer | 589 | $1.7M | $2.9K | 1.03x |
| 81404 | Molecular pathology procedure level 5 | 5.5K | $977.6K | $179.11 | 1.40x |
| 88381 | Preparation of specimen, manual | 2.8K | $394.1K | $140.85 | 2.13x |
| 81275 | Gene analysis (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 | 1.9K | $360.0K | $192.40 | 1.83x |
| 81210 | Gene analysis (v-raf murine sarcoma viral oncogene homolog B1) | 1.9K | $325.6K | $174.67 | 1.59x |
| 81403 | Molecular pathology procedure level 4 | 2.1K | $316.3K | $150.13 | 1.32x |
| 81401 | Molecular pathology procedure level 2 | 2.1K | $282.5K | $135.15 | 1.28x |
| 82378 | Carcinoembryonic antigen (cea) protein level | 3.1K | $67.4K | $21.60 | 3.65x |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | 503 | $57.8K | $114.86 | 1.69x |
| 82150 | Amylase (enzyme) level | 3.9K | $28.6K | $7.27 | 3.43x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 86 | $4.6K | $53.21 | 2.35x |
| 82945 | Glucose (sugar) level on body fluid | 278 | $1.1K | $3.79 | 1.06x |
This provider submits charges 1.5 times higher than what Medicare actually pays.
A markup ratio of 1.5x means for every $100 Medicare pays, this provider initially charges $150. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Norristown, PA | $340.6M | ✓ Clear |
| Quest Diagnostics Of Pennsylvania, Inc. | Pittsburgh, PA | $130.4M | ⚠️ Flagged |
| Health Network Laboratories, Llc | Allentown, PA | $125.3M | ⚠️ Flagged |
| Sma Medical, Inc. | Feasterville, PA | $100.9M | ✓ Clear |
| Silverpath, Inc. | Blue Bell, PA | $94.2M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data